Kaken Pharmaceutical Co., Ltd.

Kaken Pharmaceutical Co., Ltd.verified

KKPCF

Price:

$26

Market Cap:

$145.98B

Kaken Pharmaceutical Co., Ltd., a Tokyo-based company established in 1917, operates globally, specializing in the development, manufacture, and commercialization of a diverse array of medical products, medical devices, and agrochemicals. Its comprehensive portfolio spans various therapeutic areas. Key pharmaceutical offerings include Clenafin, a topical solution for onychomycosis; Artz, an anti-osteoarthritis medication; Seprafilm, an absorbable adhesion barrier used on damaged tissue; Fiblast, a spray designed for treating pressure and other skin ulcers; Regroth, a product aiding periodontal regeneration; and Hernicore, used for lumbar disc herniation. Other notable pharmaceutical products ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-12-09

Stock Exchange

OTC

Ticker

KKPCF

The Enterprise Value as of June 2026 (TTM) for Kaken Pharmaceutical Co., Ltd. (KKPCF) is 105.12B

According to Kaken Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 105.12B. This represents a change of -1.26% compared to the average of 106.47B of the last 4 quarters.

Kaken Pharmaceutical Co., Ltd. (KKPCF) Historical Enterprise Value (quarterly & annually)

How has KKPCF Enterprise Value performed in the past?

The mean historical Enterprise Value of Kaken Pharmaceutical Co., Ltd. over the last ten years is 134.55B. The current 105.12B Enterprise Value has changed 7.71% with respect to the historical average. Over the past ten years (40 quarters), KKPCF's Enterprise Value was at its highest in in the June 2016 quarter at 256.94B. The Enterprise Value was at its lowest in in the December 2023 quarter at 79.45B.

Quarterly (TTM)
Annual

Average

134.55B

Median

118.43B

Minimum

83.11B

Maximum

228.04B

Kaken Pharmaceutical Co., Ltd. (KKPCF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kaken Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 43.66%

Maximum Annual Enterprise Value = 228.04B

Minimum Annual Increase = -24.17%

Minimum Annual Enterprise Value = 83.11B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2026116.09B-3.87%
2025120.76B43.66%
202484.06B1.14%
202383.11B-8.22%
202290.56B-15.71%
2021107.43B-23.81%
2020141.00B-12.68%
2019161.47B-24.17%
2018212.93B-6.62%
2017228.04B-10.94%

Kaken Pharmaceutical Co., Ltd. (KKPCF) Average Enterprise Value

How has KKPCF Enterprise Value performed in the past?

The current Enterprise Value of Kaken Pharmaceutical Co., Ltd. (KKPCF) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

106.97B

5-year avg

98.92B

10-year avg

134.55B

Kaken Pharmaceutical Co., Ltd. (KKPCF) Enterprise Value vs. Peers

How is KKPCF’s Enterprise Value compared to its peers?

Kaken Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Luye Pharma Group Ltd. (11.54B), greater than China Shineway Pharmaceutical Group Limited (-1403750346.00), greater than Adcock Ingram Holdings Limited (11.12B), greater than Drägerwerk AG & Co. KGaA (1.60B), greater than TerrAscend Corp. (425.38M), less than PT Tempo Scan Pacific Tbk (7.25T), greater than Biotest AG (2.21B), greater than Kossan Rubber Industries Bhd (2.02B), greater than Columbia Care Inc. (810.56M), greater than Biotage AB (publ) (11.28B),

Build a custom stock screener for Kaken Pharmaceutical Co., Ltd. (KKPCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kaken Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kaken Pharmaceutical Co., Ltd. (KKPCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kaken Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Kaken Pharmaceutical Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Kaken Pharmaceutical Co., Ltd. (KKPCF)?

What is the 3-year average Enterprise Value for Kaken Pharmaceutical Co., Ltd. (KKPCF)?

What is the 5-year average Enterprise Value for Kaken Pharmaceutical Co., Ltd. (KKPCF)?

How does the current Enterprise Value for Kaken Pharmaceutical Co., Ltd. (KKPCF) compare to its historical average?